15 May 2024 - Health technology assessment guidance often recommends a 3% real annual discount rate, the appropriateness of which ...
9 May 2024 - Adalimumab-aaty will be priced at an 85% discount to Humira (adalimumab). ...
8 May 2024 - Approval was based on a pivotal Phase 3 clinical trial that demonstrated statistically significant reduction from baseline ...
9 May 2024 - Public comment period now open until 10 June 2024; requests to make oral comment during public ...
8 May 2024 - Sobi today announced that the European Commission has approved an indication extension for Aspaveli (pegcetacoplan) for ...
9 May 2024 - Australians with different types of cardiomyopathies now have access to new treatments under the Pharmaceutical Benefits Scheme. ...
7 May 2024 - TerSera Canada today announced that Health Canada has approved a supplemental new drug submission for Zoladex LA ...
8 May 2024 - Delpacibart etedesiran data from MARINA-OLE showed reversal of disease progression in multiple functional measures in DM1 ...
8 May 2024 - NICE has published evidence-based recommendations on the use of selinexor (Nexpovio) in combination with dexamethasone for ...
6 May 2024 - On Wednesday, Kendric Cromer, a 12 year old boy from a suburb of Washington, became the ...
7 May 2024 - Innovent Biologics announced that the Center for Drug Evaluation of China's National Medical Products Administration has ...
7 May 2024 - In this cohort study of cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did ...
6 May 2024 - iECURE announced today that it has received fast track designation from the US FDA for ECUR-506, ...
6 May 2024 - Azurity Pharmaceuticals announced today that the US FDA has approved Myhibbin, the only ready to use mycophenolate ...
6 May 2024 - If approved, zenocutuzumab will be the first targeted therapy for NRG1 positive cancer. ...
6 May 2024 - MannKind Corporation announced today that the US FDA has granted fast track designation of clofazimine inhalation suspension ...